Zobrazeno 1 - 2
of 2
pro vyhledávání: '"E. A. Kotteas"'
Publikováno v:
Clinical and Translational Oncology. 19:658-666
Anaplastic lymphoma kinase (ALK) rearrangement is detected in 3-7% of patients with non-small-cell lung cancer. Crizotinib is an ALK inhibitor, which was approved in 2011 for the treatment of ALK-positive lung cancer. Despite the initial enthusiasm,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ca3e40ac7ceb21a1c537d18d6c8bd1e
https://doi.org/10.1007/s12094-016-1605-y
https://doi.org/10.1007/s12094-016-1605-y
Autor:
E A, Kotteas, A, Adamopoulos, P D, Drogitis, A, Zalonis, K V, Giannopoulos, E M, Karapanagiotou, M Wasif, Saif, K N, Syrigos
Publikováno v:
In vivo (Athens, Greece). 23(3)
The case of an 81-year-old patient, initially presenting with gastrointestinal (GI) bleeding, including melena and hematemesis is reported. Endoscopy revealed an ulcerated mass of the stomach corpus with immunohistochemistry stains consistent with me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c9514e4a86ca5c8e6a761809fd0baeaa
https://pubmed.ncbi.nlm.nih.gov/19454519
https://pubmed.ncbi.nlm.nih.gov/19454519